Literature DB >> 22072805

Methylation profiling of lung cancer: a decade of progress.

Shinichi Toyooka1, Adi F Gazdar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22072805      PMCID： PMC4522280          DOI： 10.1158/1535-7163.MCT-11-0768

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN： 1535-7163            Impact factor:   6.261


× No keyword cloud information.
  2 in total

Review 1.  Cancer epigenetics reaches mainstream oncology.

Authors:  Manuel Rodríguez-Paredes; Manel Esteller
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

2.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome.

Authors:  Juan Sandoval; Holger Heyn; Sebastian Moran; Jordi Serra-Musach; Miguel A Pujana; Marina Bibikova; Manel Esteller
Journal:  Epigenetics       Date:  2011-06-01       Impact factor: 4.528
  2 in total
  4 in total

Review 1.  Epigenetic mechanisms in commonly occurring cancers.

Authors:  Lauren P Blair; Qin Yan
Journal:  DNA Cell Biol       Date:  2012-04-20       Impact factor: 3.311

2.  Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.

Authors:  Shanping Shi; Mingjun Xu; Yang Xi
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

Review 3.  Bronchial Carcinoids: From Molecular Background to Treatment Approach.

Authors:  Marta Araujo-Castro; Eider Pascual-Corrales; Javier Molina-Cerrillo; Nicolás Moreno Mata; Teresa Alonso-Gordoa
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

4.  Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma.

Authors:  Wei He; Dandan Ju; Zhijun Jie; Ai Zhang; Xin Xing; Qin Yang
Journal:  Cancer Med       Date:  2018-10-23       Impact factor: 4.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.